Syncom Formulations (India) Limited (SYNCOMF.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Address
207, Saket Nagar
Indore, 452018
India
Phone
91 73 1256 0458
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
998
First IPO Date
November 18, 2022
| Name | Title | Pay | Year Born |
| Vijay Shankarlal Bankda | MD and Executive & Non Independent Director | 6.49M | 1958 |
| Kedarmal Shankarlal Bankda | Whole Time Director | 11.78M | 1952 |
| Ankit Kedarmal Bankda | Executive Chairman | 0 | 1986 |
| Ankur Vijay Bankda | President of Export Marketing | 0 | 1985 |
| Vaishali Agrawal | Company Secretary & Compliance Officer | 0 | N/A |
| Rakesh Chandra Srivastava | Chief Marketing Officer | 0 | 1962 |
| Payal Ankur Bankda | Vice President of Human Resources | 0 | 1987 |
| Rahul Vijay Bankda | Chief Financial Officer & President of Domestic Marketing | 0 | 1980 |
Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.